Nevertheless, the observed correlations of serum IGF1 with gender, LN metastasis, and tumor stage in non-obese CRC patients spotlight the role of the IGF system in risk stratification and pathology of obesity-CRC association. Here, IGF1 is linked to colorectal carcinoma.